<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35677593</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2590-0889</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Infection prevention in practice</Title><ISOAbbreviation>Infect Prev Pract</ISOAbbreviation></Journal><ArticleTitle>Use of a multiplex polymerase chain reaction assay for the early detection of an outbreak of human parainfluenza virus type 3 infection in a nursery school during the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>100221</StartPage><MedlinePgn>100221</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100221</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.infpip.2022.100221</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Although outbreaks of parainfluenza virus type 3 (PIV-3) have been reported in children, to our knowledge none have been reported in a nursery school. As the symptoms of PIV-3 infection are similar to those of COVID-19 infection, accurate diagnosis of PIV-3 and other respiratory viruses is important during the COVID-19 pandemic.</AbstractText><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">We experienced an outbreak of upper respiratory symptoms at a nursery school in Miyagi Prefecture, Japan, from 29/5/2021 to 13/6/2021 and aimed to determine the causative organism(s).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A multiplex polymerase chain reaction (PCR) assay which enabled rapid detection of a variety of causative microorganisms of respiratory tract infections was used to analyse 13 nasopharyngeal swabs collected during the outbreak. Infection Prevention and control measures were implemented to prevent further spread of infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">All 13 samples were positive for PIV-3 infection. 2 of the 13 samples were also positive for rhinovirus/enterovirus and 1 sample was also positive rhinovirus/enterovirus and coronavirus NL 63. No samples were positive for SARS-CoV-2.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Children in school settings are especially vulnerable to respiratory viral infections, including COVID-19. Children under two years are unable to wear masks reliably, and the COVID-19 vaccine was approved only for older children. Multiplex PCR assays can be used for the rapid diagnosis of respiratory infections.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We identified an outbreak of PIV-3 in a nursery school during the COVID-19 pandemic. The investigation of the outbreak highlighted that it was important not to overlook other respiratory infections including PIV-3 during the COVID-19 pandemic. The multiplex PCR assay provided rapid and accurate diagnosis of the causative organisms in the outbreak and helped to direct appropriate interventions to control the outbreak.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Shiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizuno</LastName><ForeName>Tomoki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Shota</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horiuchi</LastName><ForeName>Yukiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ami</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imai</LastName><ForeName>Haruka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Daishi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Makiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaku</LastName><ForeName>Mitsuo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seki</LastName><ForeName>Masafumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi 983-8512, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Prev Pract</MedlineTA><NlmUniqueID>101777928</NlmUniqueID><ISSNLinking>2590-0889</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19, coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">Multiplex polymerase chain reaction assay</Keyword><Keyword MajorTopicYN="N">Outbreak</Keyword><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">PIV-3, parainfluenza virus 3</Keyword><Keyword MajorTopicYN="N">Parainfluenza virus type 3</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>9</Day><Hour>2</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35677593</ArticleId><ArticleId IdType="pmc">PMC9168608</ArticleId><ArticleId IdType="doi">10.1016/j.infpip.2022.100221</ArticleId><ArticleId IdType="pii">S2590-0889(22)00022-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeGroote N.P., Haynes A.K., Taylor C., Killerby M.E., Dahl R.M., Mustaquim D., et al. Human parainfluenza virus circulation, United States, 2011&#x2013;2019. J&#xa0;Clin Virol. 2020;124:104261. doi: 10.1016/j.jcv.2020.104261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104261</ArticleId><ArticleId IdType="pmc">PMC7106518</ArticleId><ArticleId IdType="pubmed">31954277</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg G.A., Hall C.B., Iwane M.K., Poehling K.A., Edwards K.M., Griffin M.R., et al. New Vaccine Surveillance Network. Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of Hospitalization. J&#xa0;Pediatr. 2009;154:694&#x2013;699. doi: 10.1016/j.jpeds.2008.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2008.11.034</ArticleId><ArticleId IdType="pubmed">19159905</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda H., Haneda K., Honda Y. Parainfluenza virus type 3 outbreak in a neonatal intensive care unit. Pediatr Int. 2017;59:1219&#x2013;1222. doi: 10.1111/ped.13389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.13389</ArticleId><ArticleId IdType="pmc">PMC7167953</ArticleId><ArticleId IdType="pubmed">29359411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T., Jin C.E., Sung H., Koo B., Park J., Kim S.-M., et al. Molecular epidemiology and environmental contamination during an outbreak of parainfluenza virus 3 in a haematology ward. J&#xa0;Hosp Infect. 2017;97:403&#x2013;413. doi: 10.1016/j.jhin.2017.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2017.09.003</ArticleId><ArticleId IdType="pmc">PMC7114920</ArticleId><ArticleId IdType="pubmed">28893615</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols W.G., Erdman D.D., Han A., Zukerman C., Corey L., Boeckh M. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: Insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant. 2004;10:58&#x2013;64. doi: 10.1016/j.bbmt.2003.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbmt.2003.09.010</ArticleId><ArticleId IdType="pubmed">14752780</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakiuchi S., Tsuji M., Nishimura H., Wang L., Takayama-Ito M., Kinoshita H., et al. Human parainfluenza virus type 3 infections in patients with hematopoietic stem cell transplants: The mode of nosocomial infections and prognosis. Jpn J Infect Dis. 2018;71:109&#x2013;115. doi: 10.7883/yoken.JJID.2017.424.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2017.424</ArticleId><ArticleId IdType="pubmed">29279454</ArticleId></ArticleIdList></Reference><Reference><Citation>Smielewska A., Pearson C., Popay A., Roddick I., Reacher M., Emmott E., et al. Unrecognised outbreak: Human parainfluenza virus infections in a pediatric oncology unit. A new diagnostic PCR and virus monitoring system may allow early detection of future outbreaks. Wellcome Open Res. 2018;3:1&#x2013;19. doi: 10.12688/wellcomeopenres.14732.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.14732.1</ArticleId><ArticleId IdType="pmc">PMC6338131</ArticleId><ArticleId IdType="pubmed">30687791</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan A., Liu L., Wang C., Guo H., Hao X., Wang Q., et al. Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. J&#xa0;Am Med Assoc. 2020;323:1915&#x2013;1923. doi: 10.1001/jama.2020.6130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6130</ArticleId><ArticleId IdType="pmc">PMC7149375</ArticleId><ArticleId IdType="pubmed">32275295</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F.C., Naccache S.N., Greninger A.L., Romer P., Shah R., Journal W.S. The Laboratory Diagnosis of Coronavirus Disease 2019 &#x2014; Frequently Asked Questions. Clin Infect Dis. 2020;71:2996&#x2013;3001. doi: 10.1093/cid/ciaa742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa742</ArticleId><ArticleId IdType="pmc">PMC7314175</ArticleId><ArticleId IdType="pubmed">32511679</ArticleId></ArticleIdList></Reference><Reference><Citation>Creager H.M., Cabrera B., Schnaubelt A., Cox J.L., Cushman-Vokoun A.M., Shakir S.M., et al. Clinical evaluation of the BioFire&#xae; Respiratory Panel 2.1 and detection of SARS-CoV-2. J&#xa0;Clin Virol. 2020;27:406&#x2013;409. doi: 10.1016/j.jcv.2020.104538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104538</ArticleId><ArticleId IdType="pmc">PMC7336953</ArticleId><ArticleId IdType="pubmed">32650276</ArticleId></ArticleIdList></Reference><Reference><Citation>Klompas M., Morris C.A., Sinclair J., Pearson M., Shenoy E.S. Universal Masking in Hospitals in the Covid-19 Era. N&#xa0;Engl J Med. 2020;382:e63. doi: 10.1056/NEJMp2006372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2006372</ArticleId><ArticleId IdType="pubmed">32237672</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.J., Campbell J.D., Creech C.B., Frenck R., Kamidani S., Munoz F.M., et al. Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines : Why Are Children Stuck in Neutral. Clin Infect Dis. 2021;73:336&#x2013;340. doi: 10.1093/cid/ciaa1425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1425</ArticleId><ArticleId IdType="pmc">PMC7543330</ArticleId><ArticleId IdType="pubmed">32945335</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi T., McLean K., Campbell H., Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta-analysis. J&#xa0;Glob Health. 2015;5:1&#x2013;10. doi: 10.7189/jogh.05.010408.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.05.010408</ArticleId><ArticleId IdType="pmc">PMC4593292</ArticleId><ArticleId IdType="pubmed">26445672</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg G.A., Erdman D.D., Edwards K.M., Hall C.B., Walker F.J., Griffin M.R., et al. New Vaccine Surveillance Network Study Group. Superiority of Reverse-Transcription Polymerase Chain Reaction to Conventional Viral Culture in the Diagnosis of Acute Respiratory Tract Infections in Children. J&#xa0;Infect Dis. 2004;189:706&#x2013;710. doi: 10.1086/381456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/381456</ArticleId><ArticleId IdType="pubmed">14767825</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrickson K.J. Parainfluenza viruses. Clin Microbiol Rev. 2003;16:242&#x2013;264. doi: 10.1128/CMR.16.2.242-264.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.16.2.242-264.2003</ArticleId><ArticleId IdType="pmc">PMC153148</ArticleId><ArticleId IdType="pubmed">12692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry A.M., Curns A.T., Harbour K., Hutwagner L., Holman R.C., Anderson L.J. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis. 2006;43:1016&#x2013;1022. doi: 10.1086/507638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/507638</ArticleId><ArticleId IdType="pubmed">16983614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>